ASML vs. JNJ: ASML vs. Johnson & Johnson Stock Comparison

Company Profile

ASML (ASML) is classified in the Information Technology sector (Semiconductors & Semiconductor Equipment), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.

Johnson & Johnson (JNJ) trades as ordinary local shares, while ASML (ASML) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

ASML (ASML) has an aggressive beta of 1.80, indicating higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both companies show strong equity returns, but ASML (ASML) at 65.64% is the standout with ROE above its industry range; Johnson & Johnson (JNJ) at 20.02% also sits in the top quartile.

For every dollar of sales, both ASML (ASML) at 34.14% and Johnson & Johnson (JNJ) at 16.20% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both ASML (ASML) at 44.36% and Johnson & Johnson (JNJ) at 25.74% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both ASML (ASML) at 15.58% and Johnson & Johnson (JNJ) at 6.05% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while ASML (ASML) at 28.43% is closer to the peer norm — faster per-share earnings growth for JNJ.

Growth Metrics

Financial Strength

Both ASML (ASML) at 1.49 and Johnson & Johnson (JNJ) at 1.02 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both ASML (ASML) at 0.09 and Johnson & Johnson (JNJ) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

ASML (ASML) at 0.55% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

Both pay out more than their industries’ typical bands, and JNJ more so: ASML (ASML) at 22.26% sits above the band, while Johnson & Johnson (JNJ) at 80.12% exceeds every peer in its group.

Dividend Metrics

Valuation

Both ASML (ASML) at 35.06 and Johnson & Johnson (JNJ) at 41.92 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while ASML (ASML) at 13.91 sits in the pricier quartile — ASML costs more per dollar of sales.

Both look rich against book: Johnson & Johnson (JNJ) at 8.16 sits in the upper P/B ratio quartile, and ASML (ASML) at 1,223.36 prices even higher, above its industry range.

Valuation Metrics